{"contentid": 488453, "importid": NaN, "name": "Oxford scientists detail real-world impact of coronavirus vaccination", "introduction": "Large-scale research undertaken by the University of Oxford, published as two pre-prints, shows a significant fall in COVID-19 infections after a single vaccine dose.", "content": "<p><span style=\"font-weight: 400;\">Large-scale research undertaken by the University of Oxford, published as two </span><a href=\"https://www.ndm.ox.ac.uk/covid-19/covid-19-infection-survey/results/longer-articles/vaccine-effectiveness\"><span style=\"font-weight: 400;\">pre-prints</span></a><span style=\"font-weight: 400;\">, shows a significant fall in COVID-19 infections after a single vaccine dose.</span></p>\n<p><span style=\"font-weight: 400;\">Over the coming months, data from the studies could also be critical in helping public health authorities understand how much of an antibody response, over what time period, will offer long-term protection from the disease.</span></p>\n<p><span style=\"font-weight: 400;\">Conducted in collaboration with the UK&rsquo;s Office of National Statistics (ONS) and the Department for Health and Social Care (DHSC), scientists looked at the impact of a single dose of either Vaxzevria, from AstraZeneca (LSE: AZN), or Comirnaty, from Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX).</span></p>\n<p><span style=\"font-weight: 400;\">After analyzing over 1.5 million test results, researchers found that the rates of all new infections slumped by 65%, with symptomatic infections falling 72%.</span></p>\n<p><span style=\"font-weight: 400;\">After a second dose had been given, reductions in infections and symptomatic infections were even greater (70% and 90%).</span></p>\n<p><span style=\"font-weight: 400;\">Senior researcher Koen Pouwels said the data &ldquo;supports the decision to extend the time between first and second doses to 12 weeks to maximize initial vaccination coverage and reduce hospitalizations and deaths.&rdquo;</span></p>\n<p><span style=\"font-weight: 400;\">&ldquo;However, the fact that we saw smaller reductions in asymptomatic infections than infections with symptoms highlights the potential for vaccinated individuals to get COVID-19 again, and for limited ongoing transmission from vaccinated individuals, even if this is at a lower rate,&rdquo; he added.</span></p>\n<h2><strong>Antibody responses</strong></h2>\n<p><span style=\"font-weight: 400;\">Part of the research program looks at changes in antibody levels following vaccination, and found that antibody responses to a single dose of either vaccine were lower in older individuals, especially over 60 years.&nbsp;</span></p>\n<p><span style=\"font-weight: 400;\">However, antibody responses to two doses of the Pfizer-BioNTech vaccine were high across all ages.&nbsp;</span></p>\n<p><span style=\"font-weight: 400;\">Antibody levels rose more slowly and to a lower level with a single dose of Vaxzevria, but there was no group of individuals in the study who did not respond at all to either vaccine.</span></p>\n<p><span style=\"font-weight: 400;\">Oxford University&rsquo;s David Eyre said: &ldquo;In older individuals, two vaccine doses are as effective as prior natural infection at generating antibodies to the SARS-CoV-2 virus that causes COVID-19 &ndash; in younger individuals a single dose achieves the same level of response.&rdquo;</span></p>\n<p><span style=\"font-weight: 400;\">He added: &ldquo;Our findings highlight the importance of individuals getting the second vaccine dose for increased protection.&rdquo;</span></p>", "date": "2021-04-26 13:28:00", "meta_title": NaN, "meta_keywords": "infections, dose, vaccine, single, individuals, antibody, Oxford, COVID-, vaccination, research, scientists, doses, impact, responses, pre-prints, fall", "meta_description": "Large-scale research undertaken by the University of Oxford, published as two pre-prints, shows a significant fall in COVID-19 infections after a single vaccine", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-26 13:27:59", "updated": "2021-04-26 14:07:47", "access": NaN, "url": "https://www.thepharmaletter.com/article/oxford-scientists-detail-real-world-impact-of-coronavirus-vaccination", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "oxford_university_big.jpg", "image2id": "oxford_university_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Infectious diseases, Vaccines", "topic_tag": "Coronavirus, Focus On, Public health, Research", "geography_tag": "Global, UK", "company_tag": "AstraZeneca, BioNTech, Pfizer, University of Oxford", "drug_tag": "Comirnaty, Vaxzevria", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-26 13:28:00"}